VRI: [(3~{R},5~{S},8~{R},9~{S},10~{S},13~{S},14~{S},17~{S})-17-ethanoyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-3-yl] sulfamate
VRI is a Ligand Of Interest in 8OLI designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8OLI_VRI_A_302 | 57% | 5% | 0.124 | 0.948 | 2.56 | 2.73 | 12 | 18 | 2 | 0 | 100% | 1 |
| 8OKJ_VRI_A_302 | 75% | 4% | 0.084 | 0.965 | 2.75 | 2.85 | 7 | 16 | 0 | 0 | 100% | 1 |
